CME Group Inc (NASDAQ:CME) shares traded 0.28% up during most recent session to reach at the closing price of $170.54. The stock exchanged hands 1.08 Million shares versus average trading capacity of 1.8 Million shares, yielding a market cap of $60.76 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $188.71 within the next 52-weeks. The mean target projections are based on 14 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have CME Group Inc (NASDAQ:CME) high price target of $220 and with a conservative view have low price target of $168.
Barclays “Maintained” CME Group Inc (NASDAQ:CME) in a research note issued to investors on 3/26/19 to Overweight with price target of $193.
Additionally on 3/15/19 Deutsche Bank “Maintained” CME Group Inc (NASDAQ:CME) to Buy setting price target at $214 and on 2/15/19 JP Morgan “Downgrades” the stock to Underweight at $0. Furthermore on 1/11/19 Bank of America “Downgrades” the stock to Neutral at $191.
On the other hand the company has Relative Strength Index (RSI 14) of 52.64 along with Average True Range (ATR 14) of 2.47, Consequently CME Group Inc (NASDAQ:CME)’s weekly and monthly volatility is 1.31%, 1.45% respectively. The company’s beta value is at 0.3.
In terms of Buy, Sell or Hold recommendations, CME Group Inc (NASDAQ:CME) has analysts’ mean recommendation of 2.5. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts CME Group Inc (NASDAQ:CME)’s minimum EPS for the current quarter is at $1.52 and can go high up to $1.7. The consensus mean EPS for the current quarter is at $1.61 derived from a total of 15 estimates from the analysts who have weighed in on projected earnings. However the company reported $1.86 earnings per share for the same quarter during last year.
Previously CME Group Inc (NASDAQ:CME) reported $1.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.05. The company posted an earnings surprise of 2.9%.
CME Group Inc (NASDAQ:CME)’s revenue estimates for the current quarter are $1.19 Billion according to 13 number of analysts, for the current quarter the company has high revenue estimates of $1.23 Billion in contradiction of low revenue estimates of $1.15 Billion. For the current year the company’s revenue estimates are $4.95 Billion compared to low analyst estimates of $4.79 Billion and high estimates of $5.17 Billion according to 14 number of analysts.
Currently CME Group Inc (NASDAQ:CME)’s shares owned by insiders are 0.2%, whereas shares owned by institutional owners are 87.8%. However the six-month change in the insider ownership was recorded -11.17%, as well as three-month change in the institutional ownership was recorded 0.13%.
CME Group Inc (NASDAQ:CME)’s trailing twelve month revenues are $4.31 Billion, whereas its price to sales ratio for the same period is 14.1. Its book value per share for the most recent quarter is $73.84 while its price to book ratio for the same period is 2.31, as for as the company’s cash per share for the most recent quarter is $4.06, however its price to cash per share ratio for the same period is 41.98. The stock has 5 year expected PEG ratio of 3.63 whereas its trailing twelve month P/E ratio is 29.82.